Nanog maintains human chondrocyte phenotype and function in vitro

Journal of Orthopaedic Research

Volumn 28, Issue 4, 2010, Pages 516-521

  Zheng, Hongjun ^a   Gourronc, Francoise ^a   Buckwalter, Joseph A ^a   Martin, James A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cartilage repair; Chondrocyte; Dedifferentiation; Nanog

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; FLUORESCENT DYE; LINK PROTEIN; MATRIX PROTEIN; RETROVIRUS VECTOR; SAFRANIN O; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; ACAN PROTEIN, HUMAN; BIOLOGICAL MARKER; CARTILAGE MATRIX PROTEIN; GLYCOPROTEIN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; PROTEOGLYCAN; SCLEROPROTEIN; SOX9 PROTEIN, HUMAN;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CELL FUNCTION; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MONOLAYER CULTURE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CELL DEDIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; RETROVIRUS;

AGGRECANS; BIOLOGICAL MARKERS; CELL DEDIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; PHENOTYPE; PROTEOGLYCANS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOX9 TRANSCRIPTION FACTOR; TRANSDUCTION, GENETIC;

EID: 77949527323     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.20989     Document Type: Article

References (45)

1. Brittberg M, Lindahl A, Nilsson A, et al. 1994. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331:889-895.
2. Brittberg M, Peterson L, Sjogren-Jansson E, et al. 2003. Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments J Bone Joint Surg [Am] 85-A(Suppl 3):109-115.
3. Grande DA, Pitman MI, Peterson L, et al. 1989. The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J Orthop Res 7:208-218.
4. Archer CW, McDowell J, Bayliss MT, et al. 1990. Phenotypic modulation in sub-populations of human articular chondrocytes in vitro. J Cell Sci 97(Pt 2):361-371.
5. Mayne R, Vail MS, Mayne PM, et al. 1976. Changes in type of collagen synthesized as clones of chick chondrocytes grow and eventually lose division capacity. Proc Natl Acad Sci USA 73:1674-1678.
6. von der Mark K, Gauss V, von der Mark H, et al. 1977. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 267:531-532.
7. Benya PD, Shaffer JD. 1982. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30:215-224.
8. Stokes DG, Liu G, Dharmavaram R, et al. 2001. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem J 360:461-470.
9. Bassleer C, Gysen P, Foidart JM, et al. 1986. Human chondrocytes in tridimensional culture. In Vitro Cell Dev Biol 22:113-119.
10. Zaucke F, Dinser R, Maurer P, et al. 2001. Cartilage oligomeric matrix protein (COMP) and collagen IX are sensitive markers for the differentiation state of articular primary chondrocytes. Biochem J 358:17-24.
11. Domm C, Schunke M, Christesen K, et al. 2002. Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension. Osteoarthritis Cartilage 10:13-22.
12. Jakob M, Demarteau O, Schafer D, et al. 2001. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 81:368-377.
13. Lee CR, Grodzinsky AJ, Spector M. 2003. Biosynthetic response of passaged chondrocytes in a type II collagen scaffold to mechanical compression. J Biomed Mater Res A 64:560-569.
14. Chambers I, Colby D, Robertson M, et al. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655.
15. Chambers I, Silva J, Colby D, et al. 2007. Nanog safeguards pluripotency and mediates germline development. Nature 450:1230-1234.
16. Hatano SY, Tada M, Kimura H, et al. 2005. Pluripotential competence of cells associated with Nanog activity. Mech Dev 122:67-79.
17. Wang J, Levasseur DN, Orkin SH. 2008. Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 105:6326-6331.
18. Mitsui K, Tokuzawa Y, Itoh H, et al. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631-642.
19. Hyslop L, Stojkovic M, Armstrong L, et al. 2005. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 23:1035-1043.
20. Yu J, Vodyanik MA, Smuga-Otto K, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
21. De Vries WN, Evsikov AV, Brogan LJ, et al. 2008. Reprogramming and differentiation in mammals: motifs and mechanisms. Cold Spring Harb Symp Quant Biol 73:33-38.
22. Tran D, Golick M, Rabinovitz H, et al. 2000. Hematoxylin and safranin O staining of frozen sections. Dermatol Surg 26:197-199.
23. Hough SR, Clements I, Welch PJ, et al. 2006. Differentiation of mouse embryonic stem cells after RNA interferencemediated silencing of OCT4 and Nanog. Stem Cells 24: 1467-1475.
24. Yasuda SY, Tsuneyoshi N, Sumi T, et al. 2006. NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells 11:1115-1123.
25. He S, Pant D, Schiffmacher A, et al. 2006. Developmental expression of pluripotency determining factors in caprine embryos: novel pattern of NANOG protein localization in the nucleolus. Mol Reprod Dev 73:1512-1522.
26. Singh AM, Hamazaki T, Hankowski KE, et al. 2007. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells 25:2534-2542.
27. Bellafiore M, Sivverini G, Cappello F, et al. 2006. Research of cardiomyocyte precursors in adult rat heart. Tissue Cell 38: 345-351.
28. Redvers RP, Li A, Kaur P. 2006. Side population in adult murine epidermis exhibits phenotypic and functional characteristics of keratinocyte stem cells. Proc Natl Acad Sci USA 103:13168-13173.
29. Liu TM,Wu YN, Guo XM, et al. 2009. Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cells Dev 18:1013-1022.
30. Dowthwaite GP, Bishop JC, Redman SN, et al. 2004. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 117:889-897.
31. Alsalameh S, Amin R, Gemba T, et al. 2004. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 50:1522-1532.
32. Kochupurakkal BS, Sarig R, Fuchs O, et al. 2008. Nanog inhibits the switch of myogenic cells towards the osteogenic lineage. Biochem Biophys Res Commun 365:846-850.
33. Buckwalter JA, Martin JA. 2006. Osteoarthritis Adv Drug Deliv Rev 58:150-167.
34. Caplan AI, Elyaderani M, Mochizuki Y, et al. 1997. Principles of cartilage repair and regeneration. Clin Orthop Relat Res 342:254-269.
35. Insall J. 1974. The Pridie debridement operation for osteoarthritis of the knee. Clin Orthop Relat Res 101:61-67.
36. O'Driscoll SW, Salter RB. 1984. The induction of neochondrogenesis in free intra-articular periosteal autografts under the influence of continuous passive motion. An experimental investigation in the rabbit J Bone Joint Surg [Am] 66:1248-1257.
37. Brittberg M, Nilsson A, Lindahl A, et al. 1996. Rabbit articular cartilage defects treated with autologous cultured chondrocytes. Clin Orthop Relat Res 326:270-283.
38. Gillogly SD. 2003. Treatment of large full-thickness chondral defects of the knee with autologous chondrocyte implantation. Arthroscopy 19(Suppl 1):147-153.
39. Giannoni P, Pagano A, Maggi E, et al. 2005. Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications. Osteoarthritis Cartilage 13:589-600.
40. Krishnan SP, Skinner JA, Carrington RW, et al. 2006. Collagen-covered autologous chondrocyte implantation for osteochondritis dissecans of the knee: two- to seven-year results. J Bone Joint Surg [Br] 88:203-205.
41. Chiou SH, Yu CC, Huang CY, et al. 2008. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14:4085-4095.
42. Gibbs CP, Kukekov VG, Reith JD, et al. 2005. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7:967-976.
43. Ignatova TN, Kukekov VG, Laywell ED, et al. 2002. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193-206.
44. Siu MK, Wong ES, Chan HY, et al. 2008. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol 173:1165-1172.
45. Romano G, Marino IR, Pentimalli F, et al. 2009. Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients. Drug News Perspect 22:185-196.